Taipei
Taipei
Taipei, Taiwan/Taipei, Taiwan3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . | Chemotherapy; Metastatic Gastric Adenocarcinoma; Second Line | Recruiting | Phase 1 / Phase 2 | 2026-04-09 | NCT05927857 | |
| Taiwanese Anaplastic Thyroid Cancer Registry | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, thyroid gland undifferentiated (anaplastic) carcinoma | Not yet recruiting | Not stated | 2025-08-22 | NCT07138261 | |
| The Registry Study of Genetic Alterations of Melanoma in Taiwan | Primary Melanoma of the Extremity | Recruiting | Not stated | 2025-05-06 | NCT06952400 |